MIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
A deep neural network called CHAIS may soon replace invasive procedures like catheterization as the new gold standard for monitoring heart health.
Starting with a single frame in a simulation, a new system uses generative AI to emulate the dynamics of molecules, connecting static molecular structures and developing blurry pictures into videos.
With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.
In a recent commentary, a team from MIT, Equality AI, and Boston University highlights the gaps in regulation for AI models and non-AI algorithms in health care.
In a talk at MIT, White House science advisor Arati Prabhakar outlined challenges in medicine, climate, and AI, while expressing resolve to tackle hard problems.
Researchers argue that in health care settings, “responsible use” labels could ensure AI systems are deployed appropriately.
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
Fifteen new faculty members join six of the school’s academic departments.
Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.